The Bowel CLEAnsing: A National Initiative
NCT02547571 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 3476
Last updated 2018-09-13
Summary
The purpose of this study is to compare diet, type of bowel preparation and time of colonoscopy to determine if one method is better than the other and, if they are the same, identify the one which is the most convenient for the patients.
Conditions
- Subjets Requiring a Colonoscopy
Interventions
- DRUG
-
High volume PEG split-dose
Colyte® or PegLyte® will be provided to the subject who will be asked to drink 2L of the preparation starting at 7:00 PM the day before the procedure at a rate of 240 mL every 10 minutes until completed. The second dose of 2L of preparation will be taken the morning of the colonoscopy starting 4-5 hours prior to the planned procedural time at a rate of 240 mL every 10 minutes until completed.
- DRUG
-
Low volume PEG split-dose
Bi-PegLyte® will be provided to the subject who will be asked to ingest 3 tabs of Bisacodyl 5 mg (total 15 mg) at 2:00 PM the day before the procedure. After the first bowel movement, or if there is no bowel movement within 6 hours of taking the Bisacodyl tablets, the subject will be asked to drink 1L of the solution at a rate of 240 mL every 10 minutes until the solution is completed. The second dose of 1L of preparation will be taken the morning of the colonoscopy starting 4-5 hours prior to the procedure at a rate of 240 mL every 10 minutes. Use of antacids will not be permitted within one hour of taking bisacodyl.
- DRUG
-
High volume PEG non split, day before
Colyte® or PegLyte® will be provided to the subject who will be asked to drink 4L of preparation starting at 6:00 PM the day before the procedure, at a rate of 240 mL every 10 minutes until completed.
- DRUG
-
Low volume PEG non split, same day
Bi-PegLyte® will be provided to the subject, who will be asked to ingest 3 tabs of Bisacodyl 5 mg (total 15 mg) at 2:00 PM the day before the procedure and will drink 2L of preparation the morning of the colonoscopy starting 4 hours prior to the procedure at a rate of 240 mL every 10 minutes, until completed. Use of antacids will not be permitted within one hour of taking Bisacodyl.
- OTHER
-
Clear liquid diet
- OTHER
-
Low residue diet
- OTHER
-
Early colonoscopy (stratified)
"Early" appointments: 7:30 AM to 10h30 AM
- OTHER
-
Later colonoscopy (stratified)
"Later" appointments: 10:30 AM to 4:30 PM.
Sponsors & Collaborators
-
Pendopharm
collaborator INDUSTRY -
Alan Barkun
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-03-31
- Primary Completion
- 2018-09-30
- Completion
- 2018-09-30
Countries
- Canada
Study Locations
More Related Trials
-
Effect of Single Dose of 2L PEG on Bowel Preparation in Average-risk Patients Undergoing Colonoscopy
NCT02998255 ·Status: COMPLETED ·Phase: NA
-
Comparison of Bowel Cleansing Regimens for Colonoscopy
NCT06021639 ·Status: COMPLETED ·Phase: NA
-
The Comparative Study Between Bowel Preparation Method
NCT01964417 ·Status: COMPLETED ·Phase: PHASE3
-
Bowel Preparation for Colonoscopy in the Elderly
NCT02290093 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Efficacy of High Dose Bowel Preparation Solutions for Patients With Difficult To Clean Colons For Colonoscopy
NCT02661750 ·Status: COMPLETED
-
Morning-Only 4 L PEG vs Split Dose Prep for Afternoon Colonoscopies, Endoscopist-Blinded Prospective Study
NCT02643316 ·Status: COMPLETED ·Phase: NA
-
A Randomized Prospective Trial Comparing Low-volume Bowel Preparation Methods
NCT02250196 ·Status: COMPLETED ·Phase: PHASE3
-
Barriers and Breakthroughs in IMPlementing Split Regimen OVEr Single Dose
NCT03581175 ·Status: COMPLETED
-
Comparison of Bowel Cleansing Efficacy Between Same-day Dose Versus Split Dose
NCT03315949 ·Status: COMPLETED ·Phase: PHASE3
-
A Trial of Four Different Bowel Cleansing Regimens Prior to Colonoscopy
NCT00831064 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Acceptability of Low-Residue Diet Package (Enimaclin®) as Diet Control Before Colonoscopy
NCT01665157 ·Status: COMPLETED ·Phase: NA
-
Comparison Between a 1L of Polyethylene Glycol+Ascorbic Acid as a Split Dose Bowel Preparation for Colonoscopy
NCT04758156 ·Status: UNKNOWN ·Phase: PHASE4
-
Effect of Low-volume (1L) vs Intermediate-volume (2L) Bowel Preparation on Cost-effectiveness and Quality of Life
NCT05242562 ·Status: COMPLETED ·Phase: NA
-
A Pre-endoscopic Prediction Model for Inadequate Bowel Preparation in Patients Receiving Split Dose Polyethylene Glycol Preparation
NCT02174601 ·Status: UNKNOWN
-
Bowel Preparation May Lead to a Higher Feasibility of Intestinal Infection
NCT05277090 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Effect of Simethicone on Bowel Preparation for Colonoscopy
NCT02548403 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Adding Simethicone to Split-dose Polyethylene Glycol for Bowel Preparation in a Screening Colonoscopy Setting
NCT03816774 ·Status: COMPLETED ·Phase: NA
-
Improving Outcomes for Patients Requiring Oral Bowel Preparation for Colonoscopy
NCT00693290 ·Status: UNKNOWN ·Phase: NA
-
Outcome of Colonoscopy Screening and Surveillance
NCT01827241 ·Status: UNKNOWN
-
The Interval Between the Time of Second PEG Dose and the Start of the Colonoscopy
NCT01286961 ·Status: COMPLETED
-
Evaluation of Information on Bowel Preparation for Morning Colonoscopy
NCT03650725 ·Status: COMPLETED
-
Predictors of Poor Bowel Cleansing and Capsule Endoscopy (CEPREDICT)
NCT03933371 ·Status: UNKNOWN
-
Comparison of Low-volume PEG Plus Ascorbic Acid Versus Standard PEG Solution as Bowel Cleansing for Colonoscopy
NCT01740518 ·Status: UNKNOWN
-
Managing Colorectal Cancer Prevention Procedure Wait Lists During the COVID-19 Pandemic
NCT04964596 ·Status: WITHDRAWN ·Phase: NA
-
Split-dose Versus Single-dose Polyethylene Glycol Regimen for Capsule Endoscopy
NCT02396017 ·Status: UNKNOWN ·Phase: PHASE4